Related Experiment Video

Updated: May 25, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Inhibiting platelet-stimulated blood coagulation by inhibition of mitochondrial respiration

Christopher J Barile1, Paul C Herrmann, David A Tyvoll

  • 1Department of Chemistry, Stanford University, Stanford, CA 94305, USA.

Proceedings of the National Academy of Sciences of the United States of America
|February 7, 2012
PubMed

Insights

Small molecule heterocycles targeting platelet mitochondria disrupt blood coagulation. Inhibiting mitochondrial respiration in platelets effectively deters platelet activation and blood clotting, suggesting a novel therapeutic approach.

Area of Science:

  • Biochemistry
  • Hematology
  • Pharmacology

Background:

  • Platelets, crucial for blood coagulation, possess mitochondria but their function is understudied.
  • Existing literature suggests platelet mitochondria are functional and may influence coagulation.

Purpose of the Study:

  • To investigate the hypothesis that inhibiting platelet mitochondrial function disrupts platelet activity and blood coagulation.
  • To screen small molecule heterocycles for their ability to inhibit platelet mitochondria and coagulation.

Main Methods:

  • Screening of tetrazole, thiazole, and 1,2,3-triazole heterocycles against isolated mitochondrial respiration.
  • Assessing the compounds' ability to inhibit platelet-activated blood coagulation in whole blood.
  • Utilizing a biomimetic model of cytochrome c oxidase (CcO) for heterocycle selection.

Main Results:

  • A correlation was observed between the degree of mitochondrial inhibition and the compounds' efficacy in deterring platelet stimulation.
  • Inhibition of mitochondrial respiration directly impacted platelet-activated blood clotting.
  • Compounds targeting cytochrome c oxidase showed significant effects on platelet function.

Conclusions:

  • Inhibition of platelet mitochondria effectively disrupts platelet function and blood coagulation.
  • Small molecule heterocycles targeting mitochondrial respiration represent a potential strategy for modulating blood clotting.
  • Mitochondrial inhibition is a viable mechanism for developing anti-coagulant therapies.

More Related Videos

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Related Concept Videos

The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...